Todd Bazemore, Chief Operating Officer at Kala Pharmaceuticals, Inc. (KALA), bought 10,000 shares at $5.75 ($58K) on 2020-03-16, disclosed to the SEC on 2020-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| KALA | SELL | 2025-06-04 | $13K | — | Filing → |
| KALA | SELL | 2025-01-07 | $15K | — | Filing → |
| KALA | SELL | 2024-06-27 | $22K | — | Filing → |